Subramanian Sankar serves as Executive at Nautilus Biotechnology, Inc., where they oversee executive responsibilities. Since joining the company, Subramanian Sankar has executed 4 insider transactions totaling $193.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 27, 2022 involved purchasing 5,000 shares valued at $10.2K.
Subramanian Sankar currently holds 91,250 shares of Nautilus Biotechnology, Inc. (NAUT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Subramanian Sankar has been a net buyer of NAUT stock. They have purchased $193.7K and sold $0 worth of shares.
Subramanian Sankar's most recent insider trade was on Sep 27, 2022, when they purchased 5,000 shares at $2.03 per share.
Get notified when new Form 4 filings are submitted
| $2.03 |
| Discretionary |
| Sep 16, 2022 | NAUT | $75.6K | Purchase | 35,000 | $2.16 | Discretionary |
| Sep 15, 2022 | NAUT | $87.6K | Purchase | 40,000 | $2.19 | Discretionary |